Literature DB >> 3961907

The epidemiology of onchocerciasis in Northwestern Ethiopia.

Z A Zein.   

Abstract

The prevalence of onchocerciasis has been investigated by means of quantitative skin snips for the first time in Northwestern Ethiopia. One thousand three hundred and seventy people (10%) of the population of five villages near the Sudan border were surveyed. There were 267 microfilaria carriers (19.5%) and 21 (1.5%) nodule carriers. The mean number of microfilariae per infected person was 3.6 mf/mg of skin. The infection rate in men was about three times that for women. The extent of this focus needs to be delineated.

Entities:  

Mesh:

Year:  1986        PMID: 3961907

Source DB:  PubMed          Journal:  Trop Geogr Med        ISSN: 0041-3232


  4 in total

1.  The disappearance of onchocerciasis without intervention in Tigray Region in Northwest Ethiopia.

Authors:  Moses N Katabarwa; Tekola Endeshaw; Aseged Taye; Zerihun Tadesse; Richards O Frank
Journal:  Pathog Glob Health       Date:  2014-04       Impact factor: 2.894

2.  Parasitological and clinico-epidemiological features of onchocerciasis in West Wellega, Ethiopia.

Authors:  Geme Urge Dori; Tariku Belay; Habtamu Belete; K N Panicker; Asrat Hailu
Journal:  J Parasit Dis       Date:  2011-08-23

3.  A community-based cross-sectional study of the epidemiology of onchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma Zone, southwestern Ethiopia.

Authors:  Daniel Dana; Serkadis Debalke; Zeleke Mekonnen; Wondwossen Kassahun; Sultan Suleman; Kefelegn Getahun; Delenasaw Yewhalaw
Journal:  BMC Public Health       Date:  2015-07-01       Impact factor: 3.295

4.  The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment.

Authors:  Mounkaila Noma; Honorat G M Zouré; Afework H Tekle; Peter A I Enyong; Bertram E B Nwoke; Jan H F Remme
Journal:  Parasit Vectors       Date:  2014-07-22       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.